ACLS Provider: Course

Incorrect. PEA is not a shockable rhythm; it is treated with CPR and addressing reversible causes such as hypoxia or hypovolemia.

Incorrect. A rate of 100-120 compressions per minute ensures adequate circulation without risking incomplete recoil or excessive fatigue.

Incorrect. Requires immediate defibrillation to restore organized cardiac activity.

Incorrect. Pulseless VT is a shockable rhythm requiring immediate defibrillation to restore an organized rhythm.

Incorrect. PETCO2 readings above 10 mmHg during CPR indicate adequate chest compressions and cardiac output.

Incorrect. Immediate CPR is required as asystole is a non-shockable rhythm.

Incorrect. Atropine is the first-line treatment for symptomatic bradycardia, increasing the heart rate by blocking vagal stimulation.

Incorrect. A rate of 100-120 compressions per minute optimizes perfusion without compromising cardiac filling.

Incorrect. Lidocaine is an antiarrhythmic drug used as an alternative to amiodarone for VF or pulseless VT.

Incorrect. Pediatric defibrillation begins at 2 J/kg for the first shock and increases as necessary for subsequent shocks.

Incorrect. A PETCO2 reading above 10 mmHg indicates adequate chest compressions and cardiac output during CPR.

Incorrect. Rotating team roles every 2 minutes prevents fatigue, ensuring consistent delivery of high-quality chest compressions.

Incorrect. Synchronized cardioversion at 100 J is effective for restoring a stable rhythm in unstable ventricular tachycardia.

Incorrect. Oxygen saturation should be maintained at 92-96% to avoid hypoxia and reduce the risk of hyperoxia and oxidative stress.

Incorrect. Ventricular fibrillation is the most common cause of sudden cardiac arrest and requires immediate defibrillation.

Incorrect. Waveform capnography ensures proper ET tube placement by continuously monitoring exhaled CO? levels.

Incorrect. Biphasic defibrillators deliver effective shocks within the range of 120-200 J to treat VF or pulseless VT.

Incorrect. Shouting for help ensures additional resources and a defibrillator are quickly available.

Incorrect. PETCO2 values greater than 10 mmHg during CPR indicate adequate chest compressions and blood circulation.

Incorrect. Thrombosis (pulmonary or coronary) is a reversible cause of cardiac arrest and should be addressed immediately.

Incorrect. Epinephrine is given every 3-5 minutes to enhance coronary and cerebral perfusion during cardiac arrest.

Incorrect. Placing hands on the lower half of the sternum ensures effective chest compressions without damaging other structures.

Incorrect. Compressing to a depth of 2-2.4 inches ensures adequate circulation without causing damage to internal organs.

Incorrect. PETCO2 monitoring provides continuous feedback on the quality of chest compressions and the effectiveness of resuscitation.

Incorrect. Epinephrine is administered every 3-5 minutes during pediatric cardiac arrest to enhance coronary and cerebral perfusion.

Incorrect. PEA is treated with CPR, epinephrine, and identifying reversible causes to restore organized electrical activity.

Incorrect. Adult defibrillation with a biphasic defibrillator typically starts at 120-200 J, not 360 J, depending on the manufacturer's guidelines.

Incorrect. The 15:2 ratio improves oxygenation and circulation during high-quality infant CPR performed by two rescuers.

Incorrect. The jaw thrust technique opens the airway while minimizing cervical spine movement, reducing the risk of further injury.

Incorrect. Activating EMS ensures help is on the way while you assess and initiate resuscitation.

Incorrect. Rapid defibrillation within 1 minute of witnessed VF increases the likelihood of survival and ROSC.

Incorrect. Minimizing interruptions to less than 10 seconds preserves perfusion and improves resuscitation outcomes.

Incorrect. Ventilations should be provided at a controlled rate of 6-8 breaths per minute to prevent hyperventilation.

Incorrect. Defibrillation attempts should be separated by 2-minute CPR cycles to ensure effective perfusion and rhythm evaluation.

Incorrect. Synchronized cardioversion restores organized cardiac activity in unstable VT with a pulse, preventing progression to VF.

Incorrect. TTM helps reduce neurological injury after ROSC by maintaining a target temperature between 32-36°C.

Incorrect. Pulseless VT is a shockable rhythm requiring immediate defibrillation to restore organized cardiac activity.

Incorrect. Rescuers should switch every 2 minutes to prevent fatigue and ensure high-quality compressions are maintained.

Incorrect. TTM prevents further neurological injury by maintaining a controlled core temperature after ROSC.

Incorrect. Hypothermia is a reversible cause of cardiac arrest and must be corrected to restore spontaneous circulation.

Incorrect. Calcium gluconate stabilizes the cardiac membrane and reduces the risk of life-threatening arrhythmias caused by hyperkalemia.

Incorrect. Compressing one-third the depth of the chest ensures adequate perfusion while minimizing the risk of injury.

Incorrect. Hypovolemia is a reversible cause of cardiac arrest and should be corrected with fluid resuscitation.

Incorrect. Epinephrine at 0.01 mg/kg IV/IO is administered every 3-5 minutes to enhance coronary and cerebral perfusion in children.

Incorrect. Synchronized cardioversion is used to restore a normal rhythm in unstable atrial fibrillation.

Incorrect. Delivering 10 breaths per minute ensures adequate oxygenation without causing hyperventilation.

Incorrect. Rhythm checks should be performed every 2 minutes, coinciding with rescuer role switches, to evaluate for shockable rhythms.

Incorrect. Adenosine is used to terminate reentrant arrhythmias in narrow-complex SVT by slowing conduction through the AV node.

Incorrect. Maintaining oxygen saturation within this range ensures adequate oxygenation without the risk of hyperoxia.

Incorrect. PETCO2 levels greater than 10 mmHg suggest that chest compressions are generating adequate circulation.

Incorrect. Asystole is a non-shockable rhythm and is treated with high-quality CPR and epinephrine administration.

Incorrect. With an advanced airway in place, compressions should continue uninterrupted while providing 10 breaths per minute.

Incorrect. A 30:2 ratio ensures adequate oxygenation and circulation when no advanced airway is present.

Incorrect. Atropine is the first-line drug for treating symptomatic bradycardia by increasing heart rate through vagal inhibition.

Incorrect. Amiodarone is administered as a 300 mg IV/IO bolus for refractory VF or pulseless VT.

Incorrect. Positioning the patient with a slight left tilt prevents aortocaval compression and improves venous return during CPR.

Incorrect. The correct initial dose of amiodarone for pulseless VT is 300 mg IV/IO, followed by 150 mg for a second dose if needed.

Incorrect. A compression fraction >80% ensures that the majority of CPR time is spent delivering chest compressions to improve outcomes.

Incorrect. Adenosine is the first-line drug for stable SVT, while synchronized cardioversion is used for unstable SVT.

Incorrect. Defibrillation is the primary treatment for pulseless VT, aiming to restore organized cardiac activity.

Incorrect. Compressions at 1/3 the depth of the chest ensure adequate perfusion while minimizing injury to internal organs.

Incorrect. Epinephrine is administered to increase coronary and cerebral perfusion pressure during cardiac arrest.

Incorrect. Synchronized cardioversion is used to terminate unstable SVT by restoring normal electrical activity in the heart.

Incorrect. Amiodarone 300 mg IV/IO is administered after defibrillation and epinephrine to treat refractory VF or pulseless VT.

Incorrect. IV access is preferred for rapid administration; IO is the alternative if IV access is unavailable.